H.R. 2276 (112th): To require the Director of the United States Patent and Trademark Office to conduct a study on effective ways to provide confirming genetic diagnostic test activity where gene patents and exclusive licensing exist, and for other purposes.

Introduced:

Jun 22, 2011
112th Congress, 2011–2013

Status:
Died in a previous Congress

This bill was introduced on June 22, 2011, in a previous session of Congress, but was not enacted.

Sponsor:

Debbie Wasserman Schultz

Representative for Florida's 20th congressional district

Democrat

Text:

Read Text »
Last Updated: Jun 22, 2011
Length: 3 pages

About the bill

Read CRS Summary >

History

Jun 22, 2011
 
Introduced

This is the first step in the legislative process.

This page is about a bill in the United States Congress. A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

Links & tools

Primary Source

Congress.gov

Congress.gov is updated generally one day after events occur. Legislative activity since the last update may not be reflected on GovTrack. Data via congress project.

Citation

Click a format for a citation suggestion: